NCT07484191

Contralateral Claims Study of Clareon Vivity Pro

• Status: Not Yet Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 231 (estimated)
• Sponsor: Alcon Research · Industry
• Sex: All
• Age: 22 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to test new versions of Clareon Vivity Pro intraocular lenses (IOLs) by comparing them to currently marketed IOLs.

Detailed description

Two sub-studies will be conducted. In Sub-Study B, Clareon Vivity Pro will be compared to Clareon Vivity. In Sub-Study C, Clareon Vivity Pro will be compared to TECNIS PureSee. This study will be conducted in Australia and the Philippines.

Conditions

• Aphakia
• Presbyopia

Interventions

Type	Name	Description
DEVICE	Clareon Vivity Pro IOL	Investigational UV-absorbing, blue-light filtering (BLF), foldable IOL that provides an extended range of vision from distance to near without increasing the incidence of visual disturbances. IOLs are implantable medical devices and are intended for long term use over the lifetime of the pseudophakic subject.
DEVICE	Clareon Vivity IOL	Currently marketed UV-absorbing, BLF, foldable IOL that provides an extended range of vision from distance to functional near without increasing the incidence of visual disturbances. IOLs are implantable medical devices and are intended for long term use over the lifetime of the pseudophakic subject.
DEVICE	TECNIS PureSee IOL	Currently marketed UV absorbing, violet-light filtering IOL for primary implantation for the visual correction of aphakia in adult patients with and without presbyopia. IOLs are implantable medical devices and are intended for long term use over the lifetime of the pseudophakic subject.
PROCEDURE	Cataract Surgery	Removal of the cloudy lens, followed by implantation of the IOL

Timeline

• Start date: 2026-04-01
• Primary completion: 2026-10-01
• Completion: 2027-02-01
• First posted: 2026-03-20
• Last updated: 2026-03-20